Cargando…

Menopause care in women living with HIV in the UK - A review

Advances in HIV care over the last 30 years have transformed a virtually fatal condition into a chronic, manageable one. Antiretroviral therapy (ART) has dramatically changed the outlook for people living with HIV so that most individuals with well controlled disease have a normal life expectancy. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Dragovic, B., Rymer, J., Nwokolo, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866072/
https://www.ncbi.nlm.nih.gov/pubmed/35242357
http://dx.doi.org/10.1016/j.jve.2022.100064
_version_ 1784655757230211072
author Dragovic, B.
Rymer, J.
Nwokolo, N.
author_facet Dragovic, B.
Rymer, J.
Nwokolo, N.
author_sort Dragovic, B.
collection PubMed
description Advances in HIV care over the last 30 years have transformed a virtually fatal condition into a chronic, manageable one. Antiretroviral therapy (ART) has dramatically changed the outlook for people living with HIV so that most individuals with well controlled disease have a normal life expectancy. As result of this increase in life expectancy, one-third of women living with HIV are of menopausal age. Adding to the shift in age distribution, rates of new HIV diagnosis are increasing in the over 50-year age group, likely the result of a combination of low condom use and perception of transmission risk and in women, an increased risk of HIV acquisition due to the mucosal disruption that accompanies vaginal atrophy. Many women living with HIV are unprepared for menopause, have a high prevalence of somatic, urogenital and psychological symptomatology and low rates of menopausal hormone therapy (MHT) use. Many women experience enormous frustration shuttling between their general practitioner and HIV care provider trying to have their needs met, as few HIV physicians have training in menopause medicine and primary care physicians are wary of managing women living with HIV, in part, because of fears about potential drug-drug interactions (DDIs) between MHT and ART. Several data gaps exist with regard to the relationship between HIV and the menopause, including whether the risk of HIV transmission is increased in virally-suppressed women with vaginal atrophy, whether or not menopause amplifies the effects of HIV on cardiovascular, psychological and bone health, as well as the safety and efficacy of MHT in women living with HIV. Menopausal women living with HIV deserve high quality individualised menopause care that is tailored to their needs. More research is needed in the field of HIV and menopause, primarily on cardiovascular disease and bone health outcomes as well as symptom control, and strategies to reduce HIV acquisition, encourage testing, and maintain older women in care in order to inform optimal clinical management.
format Online
Article
Text
id pubmed-8866072
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-88660722022-03-02 Menopause care in women living with HIV in the UK - A review Dragovic, B. Rymer, J. Nwokolo, N. J Virus Erad Review Advances in HIV care over the last 30 years have transformed a virtually fatal condition into a chronic, manageable one. Antiretroviral therapy (ART) has dramatically changed the outlook for people living with HIV so that most individuals with well controlled disease have a normal life expectancy. As result of this increase in life expectancy, one-third of women living with HIV are of menopausal age. Adding to the shift in age distribution, rates of new HIV diagnosis are increasing in the over 50-year age group, likely the result of a combination of low condom use and perception of transmission risk and in women, an increased risk of HIV acquisition due to the mucosal disruption that accompanies vaginal atrophy. Many women living with HIV are unprepared for menopause, have a high prevalence of somatic, urogenital and psychological symptomatology and low rates of menopausal hormone therapy (MHT) use. Many women experience enormous frustration shuttling between their general practitioner and HIV care provider trying to have their needs met, as few HIV physicians have training in menopause medicine and primary care physicians are wary of managing women living with HIV, in part, because of fears about potential drug-drug interactions (DDIs) between MHT and ART. Several data gaps exist with regard to the relationship between HIV and the menopause, including whether the risk of HIV transmission is increased in virally-suppressed women with vaginal atrophy, whether or not menopause amplifies the effects of HIV on cardiovascular, psychological and bone health, as well as the safety and efficacy of MHT in women living with HIV. Menopausal women living with HIV deserve high quality individualised menopause care that is tailored to their needs. More research is needed in the field of HIV and menopause, primarily on cardiovascular disease and bone health outcomes as well as symptom control, and strategies to reduce HIV acquisition, encourage testing, and maintain older women in care in order to inform optimal clinical management. Elsevier 2022-02-15 /pmc/articles/PMC8866072/ /pubmed/35242357 http://dx.doi.org/10.1016/j.jve.2022.100064 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review
Dragovic, B.
Rymer, J.
Nwokolo, N.
Menopause care in women living with HIV in the UK - A review
title Menopause care in women living with HIV in the UK - A review
title_full Menopause care in women living with HIV in the UK - A review
title_fullStr Menopause care in women living with HIV in the UK - A review
title_full_unstemmed Menopause care in women living with HIV in the UK - A review
title_short Menopause care in women living with HIV in the UK - A review
title_sort menopause care in women living with hiv in the uk - a review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866072/
https://www.ncbi.nlm.nih.gov/pubmed/35242357
http://dx.doi.org/10.1016/j.jve.2022.100064
work_keys_str_mv AT dragovicb menopausecareinwomenlivingwithhivintheukareview
AT rymerj menopausecareinwomenlivingwithhivintheukareview
AT nwokolon menopausecareinwomenlivingwithhivintheukareview